Cover Image

Comorbidities and Percutaneous Coronary Intervention in Elderly Patients with Acute Coronary Syndrome

Aim. To assess comorbidities in elderly patients with acute coronary syndrome (ACS) and to analyze patient subgroups with different treatment strategies in the Regional Vascular Center (RVC).Material and methods. The prospective study included 205 patients with confirmed ACS 75 years and older, the...

Full description

Saved in:

Bibliographic Details
Main Authors:	M. Yu. Gilyarov (Author), E. V. Konstantinova (Author), M. R. Atabegashvili (Author), T. D. Solntseva (Author), D. A. Anichkov (Author), А. N. Kostina (Author), R. V. Polybin (Author), A. E. Udovichenko (Author), A. V. Svet (Author)
Format:	Book
Published:	Столичная издательская компания, 2021-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

What factors are Associated with the Development of Contras-induced Nephropathy in Elderly Patients with Acute Coronary Syndrome in Real Clinical Practice?
by: M. Yu. Gilyarov, et al.
Published: (2020)

Antithrombotic Therapy after Bleeding in Elderly Polimorbid Patient: Our Time Challenge
by: M. R. Atabegashvili, et al.
Published: (2018)

How Does the Presence of Diabetes Affect the Course of Acute Coronary Syndrome in Elderly Patients in Actual Clinical Practice?
by: M. R. Atabegashvili, et al.
Published: (2019)

TREATMENT CHARACTERISTICS OF ACUTE CORONARY SYNDROME IN ELDERLY PATIENTS: PRACTICE OF N.I. PIROGOV CITY CLINICAL HOSPITAL №1
by: M. Yu. Gilyarov, et al.
Published: (2017)

WHAT ARE THE OPPORTUNITIES OF PRASUGREL IN THE TREATMENT OF PATIENTS WITH ACUTE CORONARY SYNDROME
by: M. Yu. Gilyarov, et al.
Published: (2018)

NEW PROSPECTS OF ANTITHROMBOTIC THERAPY IN PATIENTS WITH ATRIAL FIBRILLATIO AND CORONARY ARTERY STENTS: DABIGATRAN POTENTIAL
by: M. Yu. GILYAROV, et al.
Published: (2017)

The Use of Dual Antiplatelet Therapy in Acute Coronary Syndrome and Percutaneous Coronary Intervention
by: A. S. Tereshchenko, et al.
Published: (2019)

ANTITHROMBOTIC THERAPY AT PERCUTANEOUS CORONARY INTERVENTIONS
by: V. A. Sulimov
Published: (2016)

Pharmacoeconomic analysis of antithrombotic therapy in patients with acute coronary syndrome and patients with atrial fibrillation who underwent percutaneous coronary intervention
by: V. А. Ryagina, et al.
Published: (2023)

Antithrombotic strategies in patients undergoing percutaneous coronary intervention for acute coronary syndrome
by: Son V Pham, et al.
Published: (2010)

ANTIPLATELET THERAPY RESISTANCE IN PATIENTS WITH ACUTE CORONARY SYNDROME WITH ST-SEGMENT ELEVATION
by: D. H. Ainetdinova, et al.
Published: (2016)

INFLUENCE OF THE CYP3A4 ISOENZYME METABOLIC ACTIVITY AND CYP2C19 GENE POLYMORPHISMS ON CLOPIDOGREL ANTIPLATELET EFFECT IN PATIENTS WITH ACUTE CORONARY SYNDROME UNDERGOING PERCUTANEOUS CORONARY INTERVENTION
by: K. B. Mirzaev, et al.
Published: (2015)

INFLUENCE OF THE CYP3A4 ISOENZYME METABOLIC ACTIVITY AND CYP2C19 GENE POLYMORPHISMS ON CLOPIDOGREL ANTIPLATELET EFFECT IN PATIENTS WITH ACUTE CORONARY SYNDROME UNDERGOING PERCUTANEOUS CORONARY INTERVENTION
by: K. B. Mirzaev, et al.
Published: (2015)

Contrast-associated acute kidney injury after percutaneous coronary interventions in patients with acute coronary syndrome: a real-world study
by: Vladimir A. Kuznetsov, et al.
Published: (2022)

RESISTANCE TO ANTIPLATELET DRUGS (ASPIRIN, CLOPIDOGREL) IN PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION
by: V. A. Sulimov, et al.
Published: (2015)

RESISTANCE TO ANTIPLATELET DRUGS (ASPIRIN, CLOPIDOGREL) IN PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION
by: V. A. Sulimov, et al.
Published: (2015)

PRASUGREL FOR THE TREATMENT OF ACUTE CORONARY SYNDROMES AND PERCUTANEOUS CORONARY INTERVENTION: STATUS UPDATE ON THE PROBLEM
by: O. O. Shakhmatova, et al.
Published: (2018)

CASE OF LEFT ATRIUM INTRAMURAL HEMATOMA AFTER PERCUTANEOUS CORONARY INTERVENTION
by: T. S. Sukhinina, et al.
Published: (2020)

Antithrombotic Management for Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
by: A. V. Panov
Published: (2021)

DETECTING PAINLESS MYOCARDIAL ISCHEMIA IN A PATIENT WITH RESTENOSIS AFTER PERCUTANEOUS CORONARY INTERVENTION
by: M. A. Elkanova, et al.
Published: (2016)

Features of Acute Coronary Syndrome in Combination with Oncological Diseases in Elderly and Senile Patients
by: Z. D. Mikhailova, et al.
Published: (2021)

Acute Coronary Syndrome Treated with Percutaneous Coronary Intervention in Hutchinson-Gilford Progeria
by: Luciano De Simone, et al.
Published: (2023)

HOMOCYSTEINE-LOWERING THERAPY AND LONG-TERM PROGNOSIS AFTER ELECTIVE PERCUTANEOUS CORONARY INTERVENTION
by: O. O. Shakhmatova, et al.
Published: (2016)

IS THE SYNTAX SCORE SUFFICIENT TO ASSESS THE RISK FOR PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTIONS?
by: E. S. Novikova, et al.
Published: (2017)

TENEKTEPLASE: NEW POSSIBILITIES FOR SYSTEMIC THROMBOLYTIC THERAPY OF ACUTE CORONARY SYNDROME WITH ST-SEGMENT ELEVATION
by: N. A. Novikova, et al.
Published: (2016)

Relationships of Factors Affecting Self-care Compliance in Acute Coronary Syndrome Patients Following Percutaneous Coronary Intervention
by: Eun Suk Shin, RN, PhD, et al.
Published: (2013)

Clinical factors associated with the no/slow-reflow phenomenon in patients with acute coronary syndrome
by: E. V. Konstantinova, et al.
Published: (2024)

The use of percutaneous coronary intervention in black and white veterans with acute myocardial infarction
by: Sales Anne E, et al.
Published: (2006)

Frequency and Prognostic Value of Acute Periprocedural Myocardial Injury in Elective Percutaneous Coronary Interventions
by: E. O. Nalesnik, et al.
Published: (2024)

HIGH DOSES OF STATINS BEFORE PERCUTANEOUS CORONARY INTERVENTION: WHETHER THERE ARE REASONS TO USE?
by: I. S. Yavelov, et al.
Published: (2017)

Hospital mortality in acute coronary syndrome: differences related to gender and use of percutaneous coronary procedures
by: Buzón-Barrera María L, et al.
Published: (2007)

Acute Coronary Syndrome after Percutaneous Coronary Intervention: State of the Problem and Clinical Practice Data
by: I. S. Egorova, et al.
Published: (2023)

Dynamic changes in purine catabolism in patients with acute coronary syndrome that underwent percutaneous coronary intervention
by: Olga Visternichan, et al.
Published: (2019)

Left Main Coronary Artery Revascularization in Patients with Impaired Renal Function: Percutaneous Coronary Intervention versus Coronary Artery Bypass Grafting
by: Amin Daoulah, et al.
Published: (2023)

The quality of life of patients with coronary artery disease after percutaneous coronary interventions
by: Karolina Hajduga, et al.
Published: (2023)

Left main coronary disease percutaneous coronary intervention: The quest to reconcile the inconsistencies
by: Juan F. Iglesias, et al.
Published: (2021)

CARDIOPROTECTIVE EFFECT OF PHYSICAL REHABILITATION IN PATIENTS WITH ISCHEMIC-ORIGIN DIASTOLIC DYSFUNCTION AFTER PERCUTANEOUS CORONARY INTERVENTION
by: N. P. Lyamina, et al.
Published: (2015)

CARDIOPROTECTIVE EFFECT OF PHYSICAL REHABILITATION IN PATIENTS WITH ISCHEMIC-ORIGIN DIASTOLIC DYSFUNCTION AFTER PERCUTANEOUS CORONARY INTERVENTION
by: N. P. Lyamina, et al.
Published: (2015)

Geographical and socioeconomic disparities in the use of percutaneous coronary intervention in the Philippines
by: Maria Llaine J. Callanta, et al.
Published: (2022)

Residual Dyslipidemia Leads to Unfavorable Outcomes in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention
by: Bin Que, et al.
Published: (2016)